Does FEBUXOSTAT Cause Hepatic lesion? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Hepatic lesion have been filed in association with FEBUXOSTAT (Febuxostat). This represents 0.1% of all adverse event reports for FEBUXOSTAT.
8
Reports of Hepatic lesion with FEBUXOSTAT
0.1%
of all FEBUXOSTAT reports
0
Deaths
8
Hospitalizations
How Dangerous Is Hepatic lesion From FEBUXOSTAT?
Of the 8 reports, 8 (100.0%) required hospitalization.
Is Hepatic lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FEBUXOSTAT. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does FEBUXOSTAT Cause?
Gout (483)
Rash (414)
Acute kidney injury (309)
Nausea (196)
Drug ineffective (194)
Diarrhoea (189)
Pruritus (152)
Condition aggravated (148)
Arthralgia (137)
Dizziness (131)
What Other Drugs Cause Hepatic lesion?
OCTREOTIDE (296)
EVEROLIMUS (171)
RIBOCICLIB (144)
LETROZOLE (139)
CAPECITABINE (124)
ADALIMUMAB (123)
METHOTREXATE (108)
FULVESTRANT (107)
PALBOCICLIB (104)
CYCLOPHOSPHAMIDE (101)
Which FEBUXOSTAT Alternatives Have Lower Hepatic lesion Risk?
FEBUXOSTAT vs FEDRATINIB
FEBUXOSTAT vs FELBAMATE
FEBUXOSTAT vs FELIS CATUS HAIR
FEBUXOSTAT vs FELODIPINE
FEBUXOSTAT vs FENFLURAMINE